Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

WCRI Examines How Loss of Medicaid Impacts Workers’ Comp Benefits

Congress expects 11 million people to lose Medicaid coverage by 2034, which is expected to cause ripples across healthcare – including workers’ comp.
Read More →
November 9, 2026

Pennsylvania Recognizes 911 Telecommunicators as Emergency Responders

These operators will now receive similar mental health presumptions that other first responders in the state are eligible for.
Read More →
November 2, 2026

NCCI Reports on Medical Inflation

Workers’ comp increased 1.2%, with annual price growth expected to reach 2-2.5% over the next several quarters.
Read More →
November 2, 2026

Pennsylvania Advisory Council Discusses Physician Dispensing and Medical Accessibility

Drugs remained approximately 10% of medical costs, with physician-dispensed drugs accounting for 5% of total drug payments.
Read More →
October 26, 2026

Idaho Subcommittee Reviews Physician Dispensing Concerns

Spending remains high despite limits passed in 2025, with patterns of duplicate therapy, lack of medical necessity, and changes in drug strength.
Read More →
October 26, 2026

California Proposes Changes to Medical Provider Network Rules

A stakeholder meeting will take place on December 11th to review the proposed rule revisions.
Read More →
October 26, 2026

WCRI Reports on Attorney Involvement’s Impact on Claims

Workers with attorney representation reported a 10-point lower score in physical health and recovery when compared to workers without attorneys.
Read More →
October 26, 2026

NCCI Reports on Medical Treatment Dynamics

While time between injury and first medical treatment modestly increased, treatment duration did not.
Read More →
October 26, 2026

NCCI Reports on Demographic Shifts and Medical Utilization

Differences in medical utilization across demographics were linked to differences in medical conditions, industry class, and treated comorbidities.
Read More →
October 26, 2026

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

New York Broadens Pay Without Prejudice Rules

Effective January 1, 2027, payers may voluntarily cover medical treatment for up to one year while compensability determination is under review.
Read More

FDA Seeks Input on Potential Therapeutic Use of Psychedelic Drugs

A public hearing will be held on September 14th, with written comments accepted until October 5th.
Read More

In Person, In Print, and On Stage: Connect with Healthe at National Comp 2026!

Visit Healthe at Booth #415 to chat and pick up a copy of RxInformer magazine, or sit in on our panel discussion.
Read More

State Activity Surrounding Physician Dispensing

Florida, Pennsylvania, and Michigan have recently made waves regarding physician dispensing.
Read More

Emerging Therapies: Phase 3 Data for LSD-Based Drug in Major Depression

Patients taking DT120 for major depressive disorder experienced significant drops in depression symptoms.
Read More

Healthesystems at WCI 2026

Visit Healthe at Booth #921, and don’t forget to check out two educational sessions featuring Healthe leaders!
Read More
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle